Cell Signaling Technology

SignalSilence® NF-kappaB p65 siRNA I

#6261 · $381

100
Citing papers
7.7k
Combined citations
Supplier page Find this product

Research areas

Cell death mechanisms and regulation11Immune Cell Function and Interaction10NF-κB Signaling Pathways9Cancer Immunotherapy and Biomarkers8Cancer-related Molecular Pathways8Cytokine Signaling Pathways and Interactions7Immune cells in cancer6Drug Transport and Resistance Mechanisms6

Papers citing this product

1
CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours
Nature·2021·389 cit.·DOI
2
Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma
Blood·2011·334 cit.·DOI
3
<scp>PD</scp>‐L1 expression is mainly regulated by interferon gamma associated with <scp>JAK</scp>‐<scp>STAT</scp> pathway in gastric cancer
Cancer Science·2017·320 cit.·DOI
4
Phosphatidylinositol 3-Kinase Regulates the Induction of Long-Term Potentiation through Extracellular Signal-Related Kinase-Independent Mechanisms
Journal of Neuroscience·2003·214 cit.·DOI
5
Caveolae-mediated Internalization of Occludin and Claudin-5 during CCL2-induced Tight Junction Remodeling in Brain Endothelial Cells
Journal of Biological Chemistry·2009·200 cit.·DOI
6
Rhamnetin and Cirsiliol Induce Radiosensitization and Inhibition of Epithelial-Mesenchymal Transition (EMT) by miR-34a-mediated Suppression of Notch-1 Expression in Non-small Cell Lung Cancer Cell Lines
Journal of Biological Chemistry·2013·196 cit.·DOI
7
Inhibition of LDH-A by oxamate induces G2/M arrest, apoptosis and increases radiosensitivity in nasopharyngeal carcinoma cells
Oncology Reports·2013·177 cit.·DOI
8
Calcium–Calmodulin-Dependent Kinase II Modulates Kv4.2 Channel Expression and Upregulates Neuronal A-Type Potassium Currents
Journal of Neuroscience·2004·169 cit.·DOI
9
Intracellular delivery of protein drugs with an autonomously lysing bacterial system reduces tumor growth and metastases
Nature Communications·2021·167 cit.·DOI
10
STAT3 Induction of miR-146b Forms a Feedback Loop to Inhibit the NF-κB to IL-6 Signaling Axis and STAT3-Driven Cancer Phenotypes
Science Signaling·2014·166 cit.·DOI